0 Kommentare
0 Geteilt
307 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Buerger's Disease Market is driven by regenerative therapiesThe Buerger’s Disease Market encompasses a range of therapeutic solutions designed to treat thromboangiitis obliterans, a non-atherosclerotic vascular disorder primarily affecting small- and medium-sized arteries and veins. Leading product categories include vasodilators, prostaglandin analogues, antiplatelet agents, and emerging regenerative options such as stem cell–based...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Fondaparinux Market Growth Driven by Anticoagulant Therapies, Cardiovascular Care, and Generic Drug ApprovalsRegional Overview of Executive Summary Fondaparinux Market by Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the fondaparinux market in the forecast period 2023-2030. The expected CAGR of fondaparinux market is tend to be around 6.7% in the mentioned forecast period. The market was valued at USD 574.94 million in 2022, and it would grow up to USD...0 Kommentare 0 Geteilt 789 Ansichten 0 Bewertungen
-
Transient Ischemic Attack Diagnostics is driven by Increasing Awareness of Early DetectionTransient ischemic attack (TIA), commonly known as a mini-stroke, is a transient episode of neurological dysfunction caused by focal brain or retinal ischemia without acute infarction. TIAs have the same underlying pathogenic mechanisms as strokes, including thrombosis, embolism, or systemic hypoperfusion. Diagnosing TIAs is critical as it can help predict future risk of major stroke and guide...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Transient Ischemic Attack Market is driven by advanced diagnosticsThe Transient Ischemic Attack (TIA) Market comprises a diverse range of diagnostic, therapeutic, and monitoring products designed to manage and prevent transient ischemic attacks. These offerings include non-invasive imaging modalities such as CT scans and MRI, point-of-care biomarker assays, antiplatelet and anticoagulant medications, and advanced wearable devices for continuous patient...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen